Article
Cancer stem cells as mediators of treatment resistance in brain tumors: status and controversies.
Neoplasia (New York, N.Y.) - 1 Nov 2007
Sakariassen Per Ø, Immervoll Heike, Chekenya Martha
Abstract excerpt
Malignant primary brain tumors are characterized by a short median survival and an almost 100% tumor-related mortality. Despite the addition of new chemotherapy regimes, the overall survival has improved marginally, and radiotherapy is only transiently effective, illustrating the profound impact of treatment resistance on prognosis. Recent studies suggest that a small subpopulation of cancer stem cells (CSCs) has...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
